The regulatory agency has approved for local medicine ‘Cryptolepis Sanguinolenta’ popularly known as Nibima for clinical trial on Covid -19 treatment.
The Food and Drugs Authority (FDA) has therefore approved Ghana’s first herbal medicine for clinical trial on COVID-19 treatment.
This follows results from laboratory studies conducted by the Kwame Nkrumah University of Science and Technology (KNUST) research team.
This means the medicine, Cryptolepis Sanguinolenta, locally known as Nibima stands a better chance of being used to treat COVID-19 if it is approved after the trial.
A statement signed and released by FDA CEO Delese Darko said the authority remains committed to protect the health and safety of consumers.
Below is the full statement.
So far, the country has recorded a surge in death toll of 416 with 5,358 Active cases and 794 new cases.
The President, Nana Akufo-Addo has however, announced restrictions to help contain the spread of the virus.
Thus, weddings, funerals, concerts and parties are banned.
Meanwhile, private burials not more than 25 people can take place.
He said this during his 23rd address to the nation.
For any adverts kindly send your ads or stories via email – bibiniproduction@gmail.com or WhatsApp 0557449200
SUBSCRIBE to our YouTube Channel @bibinitv Instagram @bibini_tv Twitter @bibiniqwaku
Ghana 
Discussion about this post